MEPIRAPIM is an indole-based cannabinoid which differs from JWH-018 by having a 4-methylpiperazine group in place of the naphthyl group and has been used as an active ingredient in synthetic cannabis products. It was first identified in Japan in 2013, alongside FUBIMINA. MEPIRAPIM acts as a T-type calcium channel inhibitor and is only minimally active at the CB1 receptor.
Legality Sweden's public health agency suggested to classify MEPIRAPIM as hazardous substance on November 10, 2014.
See also APICA AM-2201 JWH-073 JWH-250 JWH-200 List of JWH cannabinoids List of AM cannabinoids THJ-2201
References


